BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.700
-0.080 (-4.49%)
Jul 19, 2024, 4:00 PM EDT - Market closed
BioAtla Market Cap
BioAtla has a market cap or net worth of $81.80 million as of July 22, 2024. Its market cap has decreased by -36.93% in one year.
Market Cap
81.80M
Enterprise Value
3.09M
1-Year Change
-36.93%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $81.80M, a decrease of -85.84%. That is a compound annual growth rate of -41.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 81.80M | -30.62% |
| Dec 29, 2023 | 117.90M | -62.00% |
| Dec 30, 2022 | 310.30M | -57.09% |
| Dec 31, 2021 | 723.10M | -31.39% |
| Dec 31, 2020 | 1.05B | 82.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 84.08M |
| AN2 Therapeutics | 83.22M |
| Sangamo Therapeutics | 82.40M |
| Instil Bio | 82.27M |
| Genenta Science | 82.16M |
| Serina Therapeutics | 81.70M |
| DBV Technologies | 80.83M |
| Chimerix | 80.66M |